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A B S T R A C T
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Background: Intravascular lithotripsy (IVL) can be used to assist stent deployment in severe coronary artery
calcifications (CAC).
Methods: Studies employing IVL for CAC lesions were included. The primary outcomes included clinical and
angiographic success. The secondary outcomes, including lumen gain, maximum calcium thickness, and calcium
angle at the final angiography site, minimal lumen area site, and minimal stent area site, were analyzed by the
random-effects model to calculate the pooled standardized mean difference. Tertiary outcomes included safety
event ratios.
Results: Seven studies (760 patients) were included. The primary outcomes: pooled clinical and angiographic
success event ratio parentage of IVL was 94.4% and 94.8%, respectively. On a random effect model for standard
inverse variance for secondary outcomes showed: minimal lumen diameter increase with IVL was 4.68 mm (pvalue < 0.0001, 95% CI 1.69–5.32); diameter decrease in the stenotic area after IVL session was − 5.23 mm (95
CI –22.6–12.8). At the minimal lumen area (MLA) and final minimal stent area (MSA) sites, mean lumen area
gain was 1.42 mm2 (95% CI 1.06–1.63; p < 0.00001) and 1.34 mm2 (95% CI 0.71–1.43; p < 0.00001),
respectively. IVL reduced calcium thickness at the MLA site (SMD − 0.22; 95% CI − 0.40–0.04; P = 0.02); calcium
angle was not affected at the MLA site. The tertiary outcomes: most common complication was major adverse
cardiovascular events (n = 48/669), and least common complication was abrupt closure of the vessel (n = 1/
669).
Conclusions: Evidence suggests that IVL safely and effectively facilitates stent deployment with high angiographic
and clinical success rates in treating severely calcified coronary lesions.

Abbreviations: MACE, Major Adverse Cardiovascular Events; MI, Myocardial Infarction; TVR, Target Vessel Revascularization; CM, Cardiac Mortality; CDissection, Coronary Dissections; ST, Stent Thrombosis.
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1. Introduction

“unstable angina,” “stable angina,” “calcified coronary artery disease,”
“failed percutaneous coronary intervention,” “stent under expansion,”
and “drug-eluting stent,” These terms were combined using Boolean
operators (“AND” or “OR”), and final results from all the possible
combinations were downloaded into an EndNote library. Additional
studies were identified by reviewing the reference lists of potentially
relevant studies (Supplementary S1). Our study involved analysis of
de-identified data and was exempt from institutional board review (IRB)
approval.

Clinical Perspective
What is known:
• The most common cause of PCI failure can be secondary to severe
coronary artery calcification.
• Athero-ablative procedures can be used to modify calcium, allowing
more optimal stent delivery and expansion in such complex coronary
cases. These adjuvant techniques are associated with an increased
risk of complications while at the cost of stent under-expansion, stent
damage, or malposition if the calcium modification is not optimal.

2.2. Selection criteria
Studies were included if they met the following inclusion criteria: 1)
studies that primarily evaluated coronary shockwave IVL, 2) studies of
patients with coronary circulation calcified disease. For inclusion, the
studies had to report data that evaluated the effectiveness of shockwave
IVL for coronary circulation with baseline pre- and post-procedural
changes in vessel diameter. Studies that included adjunctive modal
ities such as atherectomy and cutting balloons, but which primarily
employed IVL with a goal to obtain gain in lumen features and stent
optimization, were also included in the present analysis. Furthermore,
studies that included a head-to-head comparison of atherectomy and
cutting balloons were excluded from our quantitative analysis. We also
excluded patients under 18 years of age from the present analysis.

What is New
• Intravascular lithotripsy delivers circumferential, unfocused, and
pulsatile energy to disrupt calcium within the target lesion safely
with > 90% clinical and angiographic success. The purpose is to
fracture the calcified plaque to allow proper expansion with a
balloon to gain enough lumen diameter to pass and deploy the DES
successfully.
What Are the Clinical Implications?
• Intravascular lithotripsy can offer a significant improvement in the
vessel lumen to facilitate coronary stent delivery and deployments in
severely calcified coronary arteries.

2.3. Data extraction
Two authors (Y.S and J.A) independently reviewed the search results
for studies that met the eligibility criteria. Uncertainty regarding study
inclusion was resolved by consensus with a third author (W.U). The first
phase of screening involved screening of titles and abstracts meeting
selection criteria. The second screening phase required full-text reading
of articles that identified items for data extraction based on the selection
criteria. The mean and standard deviation of vessel characteristics preIVL, post-IVL, and post stenting were tabulated.

Percutaneous coronary intervention (PCI) failure is a clinical chal
lenge of the coronary artery cases that require intervention. The most
common cause of PCI failure can be secondary to severe coronary artery
calcification [1,2]. Athero-ablative procedures such as excimer lasers,
rotational and orbital atherectomy, cutting balloons, and high-pressure
non-compliant balloon catheters can be used to modify calcium,
allowing more optimal stent delivery and expansion in such complex
coronary cases [3]. These adjuvant techniques are associated with an
increased risk of complications while at the cost of stent underexpansion, stent damage, or malposition if the calcium modification is
not optimal. These complications secondary to PCI with atherectomy or
assisted measures may be associated with increased rates of stent
thrombosis and restenosis that may contribute to mortality [4–6].
Coronary intravascular lithotripsy (IVL) has been recently developed
in order to manage coronary artery calcification. IVL delivers circum
ferential, unfocused, and pulsatile energy to disrupt calcium within the
target lesion safely. The purpose is to fracture the calcified plaque to
allow proper expansion with a balloon to gain enough lumen diameter to
pass and deploy the DES successfully [7]. The ultrasonic waves travel
through a balloon-based small size catheter disrupting only the super
ficial and deep calcium deposits with limited risk of vascular rupture or
dissection [8,9].
Intravascular lithotripsy has been shown to offer better safety and
lower procedure-related complications. We sought to quantify an effect
size through a meta-analysis of all available studies for IVL outcomes in
severely calcified coronary lesions.

2.4. Outcomes
The primary outcomes for this analysis were clinical and angio
graphic success event ratios. The secondary outcomes included minimal
lumen diameter (MLD), diameter stenosis (DS), lumen area, maximum
calcium thickness, and calcium angle at minimal lumen area (MLA) and
final minimal stent area (MSA). We also reviewed descriptive measures
of final angiographic outcomes, including acute luminal gain, stent de
livery, angiographic success, and clinical success. The safety measures
studied were MACE (composite of myocardial infarction, target vessel
revascularization, and cardiovascular mortality), coronary dissection,
stent thrombosis, slow reflow, and no-reflow. Clinical/Procedural success
was defined as ability to produce residual diameter stenosis < 50% in
coronary artery by preventing major adverse cardiovascular events.
Angiographic success was defined as successful stent delivery with a re
sidual diameter stenosis value of 50% in the absence of significant
procedural complications. Severe complications in all the studies
included were defined as either angiographically (radio-opacities
involving both sides of the arterial wall and length of at least 15 mm) or
IVL (IVUS) or OCT [presence of ≥ 270 degrees of calcium on at least 1
cross-section].

2. Methods
2.1. Data source

2.5. Statistical analysis

A bibliographical search of PubMed, EMBASE, Cochrane Central,
and ClinicalTrials.gov databases for randomized clinical trials and
observational studies was performed from inception until September
2020. The search items included medical subject headings (MeSH) and
keywords: “intravascular shockwave lithotripsy,” “coronary litho
tripsy,” “IVL,” “S-IVL,” “acute coronary syndrome,” “ST-elevation
myocardial infarction,” “non-ST elevation myocardial infarction,”

This meta-analysis followed the Preferred Reporting Items for Sys
tematic reviews and Meta-Analyses guidelines [10]. Statistical analysis
was performed using the Cochrane Review Manager (RevMan) version
5.3. Data from each study that met the inclusion criteria were extracted
into a table. The table’s data elements included the study’s country, age
of participants, sex of participants, sample size, comorbidities of
2
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participants, procedural parameters, safety, and follow-up. Data re
ported in median was converted to mean with standard deviation using a
standardized Hozo equation [11]. Outcome variables were analyzed by
a random-effects model (inverse variance) to calculate the pooled
standardized mean difference with a statistical significance of proba
bility value p < 0.05 [12]. The “test for overall effect” was reported as z
value corroborating the 95% confidence interval’s inference. Descrip
tive statistics were performed for outcome measures that did not have
data in a format to perform mean inverse variance.
Higgins I-squared (I2) was determined as a measure of statistical
heterogeneity where values of ≤ 50% corresponded to low to moderate
heterogeneity while values ≥ 75% indicated high heterogeneity [13].
The publication bias was depicted graphically and numerically as a
forest plot and Egger’s Regression Equation (ERE) [14]. The included
articles’ quality assessment was performed using the Cochrane guide
lines for the systematic review and meta-analysis, and New
castle–Ottawa scale (NOS), where each study was screened for five
different types of bias (selection, performance, detection, attrition, and
reporting bias). The NOS scale score ranged from 0 to 9; a score of 7 and
above is considered high quality.

6fr, respectively. The baseline demographic, lesion, and procedural
characteristics are shown in Table 1. The included studies’ methodo
logical quality was moderate based on the mean Newcastle Ottawa Scale
(NOS) score of 6. The detailed NOS is given in Supplementary S2.
3.1. Primary outcome
The event ratios of pooled clinical/procedural (success events n =
662/sample total706). and angiographic success (success events n = 684
/sample total n = 706) was 94.4% and 94.8%, respectively (Fig. 2).
3.2. Secondary outcome efficacy of pre- and post- intravascular
lithotripsy in calcified coronary disease on angiography
A total of 483 and 467 patients were included in comparing MLD in
pre-IVL and post IVL groups, respectively. The overall MLD diameter
change with IVL was 4.68 mm (p-value < 0.0001, 95% CI 1.69–5.32)
(Fig. 3). Sensitivity analysis was performed, and I2 dropped to 0% by
removing study Brinton DISRUPT CAD I, Lelasi SMILE, Saito DISRUPT
CAD 4, and Hill DISRUPT CAD III (Supplementary S3). The likely cause
of heterogeneity caused by these studies was due to selection bias given
the variation in sample size and angiographic features. A total of 181
patients in each pre-IVL and post-IVL group were included for compar
ison of DS. The overall DS change in the stenotic area after the IVL
session was − 0.84 (95% CI: − 7.63 to 5.96) (Fig. 4). The mean acute
luminal gain in post IVL and post-stent was 1.21 mm and 1.89 mm,
respectively (see Table 2.).

3. Results
INCLUDED STUDIES: The electronic search resulted in 2,901 arti
cles that underwent title and abstract screening. Following duplicate (n
= 149) removal and irrelevant items (n = 2687), 70 articles were
reviewed in full-text form. Based on the selection criteria, 7 original
studies, including one subgroup study, qualified for final analysis
[15–21]. The detailed search strategy is shown in the PRISMA flow di
agram (Fig. 1). One study included in-stent coronary artery calcification
and used IVL in this population [19]. All the studies other than SMILE
registry used IVL on coronary artery calcification and then underwent
stent deployment [15–18,20]. A total of 760 patients were included in
our study. The mean age of the population was 72.4 years. The most
common comorbidity was hypertension. The most common target vessel
was the left anterior descending artery. Severe and moderate calcifica
tions were present in up to 94% and 6% of cases, respectively. The mean
balloon size, pressure, and catheter size was 4.0 × 12 mm, 6 atm, and

3.3. Pre- and post- intravascular lithotripsy efficacy at minimal lumen
area
The MLA in pre-IVL (n = 122) and post-IVL(n = 115) showed a mean
gain of 1.31 mm2 (95% CI 1.02–1.59; P < 0.00001) (Fig. 5A). Further
more, statistically significant difference in the maximum calcium
thickness (SMD − 0.22; 95% CI − 0.40–0.04; P = 0.02) while calcium
angle among pre- and post-IVL at MLA site was not statistically signifi
cant (SMD − 0.25; 95% CI − 0.68–0.19; p = 0.26) (Fig. 5B-C).

Fig. 1. PRISMA Flow of the search strategy for systematic review and meta-analysis Caption. PRISMA flow diagram is a summary of systematic search methods that
explain how the eligible studies were screened and included in analysis. N; number of articles.
3
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Table 1
Baseline demographics and comorbidities of the study population.
Author

Brinton (DISRUPT
CAD I) 2017 15

Ali ZA (DISRUPT CAD OCT
sub-group) – 2017 16

Ali (DISRUPT CAD
II) – 2019 17

Aksoy
2019 18

Hill (DISUPT CAD
III) 2020 20

Lelasi (SMILE)
2020 19

DISRUPT CAD
IV 21

Country

Multi-national

Multi-national

Multi-national

Germany

Italy

Japan

Age (Years)
Male % (n)
Sample Size (n)
ACS % (n)
HTN % (n)
DM % (n)
Dyslipidemia %
(n)
Smoking % (n)
TIA/Stroke
Angina
Classification
0
I
II
III
IV

73
80
60
40
80
30
80

71 ± 10
80 (25)
31
42 (13)
24 (77)
7 (23)
26 (83)

72 ± 10
78 (94)
120
26 (31)
80 (96)
32 (38)
72 (86)

76
51
71
45
93
34
62

US, UK, France &
Germany
71.2 ± 8.6
76.6 (294)
384
18.0(69)
89.1(342)
40.1(154)
89.1(342)

69.2 ± 3.8
76 (26)
34
44.1(15)
85.2(29)
52.9(18)
82.3(28)

62.3 ± 4.5
72 (63).

15 (9)
13 (8)

7 (23)
–

13 (16)
3 (4)

37 (26)
17 (12)

12.2(47)
7.6 (29)

50(17)

19 (32)
29 (48)
10 (17)
2 (3)

13 (42)
16 (52)
1 (3)
1 (3)

±7
(48)
(24)
(48)
(18)
(48)

± 10
(72)
(32)
(66)
(24)
(45)

48/381 (12.6)
56/381 (14.7)
142/381 (37.3)
126/381 (33.1)
9/381 (2.4)

Abbreviations: ACS: Acute Coronary Syndrome; HTN: Hypertension; DM: Diabetes Mellitus; TIA: Transient Ischemic Attack.

Fig. 2. Event Ratios of Clinical/Angiographic and Procedural Success in IVL patients.

Fig. 3. Forest plot showing outcomes of minimal lumen diameter (MLD) in patients that received IVL as compared to pre-IVL.
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Fig. 4. Forest plot showing outcomes of diameter stenosis in patients that received IVL as compared to pre-IVL.

3.4. Pre- and post- intravascular lithotripsy efficacy at final minimal stent
area

layers of calcium in coronary artery calcification. Owing to ease of use,
the low-pressure balloon inflation, low frequency of serious complica
tions, and small (6F) guide catheter requirement, IVL is preferred over
prior calcium debulking techniques. Our meta-analysis findings suggest
that IVL might be an effective adjunctive procedure to help with coro
nary artery calcifications.
Brinton et al. DISRUPT CAD I was the first study to assess the
effectiveness of IVL for coronary artery calcification [15]. A total of 60
patients were enrolled from seven different hospitals in five countries.
The included study population had ≥ 1 lesion requiring PCI with heavy
calcification, diameter stenosis ≥ 50%, and lesion length ≤ 32 mm. The
study’s primary outcome was to assess clinical efficacy: the ability to
reduce mean diameter stenosis < 50% with no evidence of MACE at 30
days follow-up. DISRUPT CAD results showed a mean decrease of cal
cium angle, calcium thickness, lumen area was 24◦ , 0.03 ± 0.01 mm,
and 4.24 ± 2.34 mm, respectively. Calcium fracture was achieved in >
25% of the lesions with a mean acute diameter gain of 2.1 mm. The
study resulted in favorable outcomes to deploy stents in up to 95% of
patients who underwent IVL. Subsequently, Ali et al. performed a sub
group study of CAD I using optical coherence tomographic (OCT) im
aging for reporting the angiographic outcomes of IVL [16]. The Authors
included 31 patients in subgroup analysis that underwent IVL and
resulted in a calcium fracture that was highest in heavily calcified le
sions (highest vs. lowest percentile of calcium: 77.8 % vs. 22.2 %, p =
0.057). The mean acute luminal after IVL was 2.1 mm2, which can be
expanded to 5.94 ± 1.98 mm2 with DES. The mean stent expansion was
112.0 ± 37.2%. Deep dissection, as part of the IVL procedure, was seen
in 13% of the cases. The population analyzed did not experience vessel
perforation, slow flow/no reflow, or closure after the IVL procedure.
Furthermore, DISRUPT CAD II data on IVL was also reported by the same
authors (ALI et al.), who assessed the efficacy of IVL in severely calcified
lesions [17]. The study’s primary outcome was MACE (target vessel
revascularization, myocardial infarction, and cardiac mortality) after
IVL. This study reported a mean drop in calcium angle, calcium thick
ness, lumen area by 51◦ , 0.04 ± 0.2 mm, and 4.83 ± 3.04 mm, respec
tively. The post-IVL acute luminal gain was 0.83 ± 0.47 mm that
increased to 7.7 ± 7.1% by DES implantation with residual stenosis of
32.7 ± 10.4%. IVL associated MACE developed in 7 (5.8%) patients with
non-Q wave myocardial infarction. The rest of the complication review
assessment at 30 days follow-up showed no perforation, dissection, or
early in-stent stenosis. The most recent study performed by Aksoy et al.
in 2019 [18] reported an improvement in stenosis from a baseline of
71.8 ± 13.1% to 45.1 ± 17.4% after IVL and 17.5 ± 15.2% after
stenting. Luminal diameter improvement from 1.01 ± 0.49 mm to 1.90
± 0.61 with IVL and 2.88 ± 0.56 mm after stenting. An 84.6% success
rate has been reported in patients who had IVL as their primary pro
cedure. The Intravascular lithotripsy for the Management of un-dilatable
coronary stent: (SMILE) study assessed the safety of IVL in calcified instent restenosis. The study reported that IVL was a success in 87.1% of
cases with significant improvement in minimal stent diameter (pre IVL
0.81 mm; post IVL 3.23 mm; p = 0.00001) and minimal stent crosssectional area (pre IVL 3.35 mm; post-IVL 7.61 mm; p = 0.00001)
[19]. In September 2020 CAD III prospective study by Hill et al. 431
patients were enrolled from 47 sites in the US, UK, France, and Germany.
CAD III was a non-randomized, single-arm study with performance

The mean lumen area for the MSA site in pre-IVL (n = 240) and postIVL(n = 249) showed a mean gain of 1.06 mm2 (95% CI 0.71–1.41; P <
0.00001; I2 = 66%). There was no statistically significant difference of
maximum calcium thickness (SMD − 0.18; 95% CI − 0.43–0.06; p = 0.14;
I2 = 34%) and calcium angle (SMD − 0.07; 95% CI − 0.37–0.22; p =
0.62) among pre- and post-IVL at final MSA site (Fig. 6A-C).
3.5. Intravascular lithotripsy safety
In general, the complication rate was low. In 669 patients, the most
common complication was MACE at 30-day follow-up (n = 48). During
the 30-day follow-up, myocardial infarction, including periprocedural
MI (n = 44) and target vessel revascularization (n = 7), were the two
leading MACE constituents. In-hospital MACE (n = 39) were the second
most complications. Among in-hospital MACE, periprocedural MI (n =
34) was the leading MACE component. Coronary dissection (n = 12) was
the second most common in-hospital complication. The abrupt closure
of vessels and perforation were the least common complications. None
of the studies reported any slow reflow or no-reflow events after IVL
sessions. A summary of IVL complications based on follow-up are shown
in Fig. 7.
PUBLICATION BIAS: The plot’s vertical axis used standard error to
estimate the study’s sample size, plotting large population studies on top
and smaller at the bottom. The horizontal spread reflected the power
and effect size of the included studies. Our funnel plot was not sym
metrical on visual assessment, indicating that the limited scatter might
be due to publication bias (Supplementary S4). The numerical assess
ment of publication bias was done using Egger’s regression model that
failed to show any publication bias or small study effects (ERE ≈ p >
0.05). Furthermore, the heterogeneity among the outcomes of the
included studies was self-explicable. First, as per the Cochrane hand
book of the systematic review and meta-analysis, if the total count of
included studies is less than ten, it is not possible to differentiate be
tween true heterogeneity and findings merely by chance. Second, while
all the studies unanimously supported the IVL, the sampling error could
explain the high percentage of variability.
4. Discussion
This comprehensive meta-analysis of 7 studies with 760 patients, IVL
enhanced MLD and lumen area at MLA and final MSA site. The pooled
clinical and angiographic success of IVL is 94%. However, IVL was not
associated with a change in diameter stenosis, calcium angle at any
vessel point except maximum calcium thickness at the MLA site. The
most common complications in-hospital and to 30-days were including
periprocedural MI and coronary dissection.
Coronary artery calcifications may pose a challenge to the successful
delivery of stent platforms, and even if successfully delivered, may result
in stent under-expansion, which may, in turn, might lead to further
complications including MACE, restenosis, target lesion failure, and
stent thrombosis. Coronary IVL is a contemporary intervention that uses
ultrasonic waves without athero-ablation to target superficial and deep
5
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Table 2
Angiographic lesion characteristics, and procedural characteristics of the study population.
Author

Brinton
(DISRUPT CAD I)
2017 15

Lesion Angiographic Characteristics
Calcium angle
Calcific angle was
definition
defined as lowattenuation signal
with sharply
delineated borders

Ali ZA (DISRUPT CAD OCT
sub-group) – 2017 16

Ali (DISRUPT CAD II) –
2019 17

Aksoy
2019 18

Hill (DISUPT
CAD III) 2020 20

Lelasi
(SMILE)
2020 19

DISRUPT CAD 4

Calcification angle was
measured using a protractor
centered on the lumen. If
there were > 1 calcium
deposits present in a single
cross-sectional frame, the
angle was defined as the sum
of the angles of each
individual calcium deposit
for that cross section.

Calcification angle was
measured using a protractor
centered on the lumen. If
there were > 1 calcium
deposits present in a single
cross-sectional frame, the
angle was defined as the sum
of the angles of each
individual calcium deposit
for that cross section.
1 (0.8)

–

Max calcium site
was defined as
the site with
maximum
calcium arc

–

Key parameter,
such as calcium
angle, were
determined and
defined using
OCT

13
(16.7)
34
(43.6)

6 (1.6)

Protected LMA n (%)

1(2)

LAD

28 (47)

14 (45.1)

75 (62.5)

Circumflex
RCA

8 (13)
23 (38)

5 (16.1)
12 (38.7)

14 (11.7)
30(25)

Lesion Localization
Ostial
Proximal
Mid
Distal
Reference vessel
3 (2.6–3.2)
diameter, mm
(median IQR
range, or mean ±
SD)
Minimal lumen
0.9 (0.6–1.1)
diameter, mm
(median IQR
range, or mean ±
SD)
Diameter stenosis %
73 (59–77)
(median IQR
range, or mean ±
SD)
Lesion length, mm
18 (14–25)
(mean ± SD)
Calcified length, mm
21 (12, 25)
(mean ± SD)
Calcifications: severe
S 60 (1 0 0)
(s) n (%),
moderate (m) (n
(%)
Concentric
47 (78)
calcification n (%)
Eccentric
13 (22)
calcification n (%)
Bifurcation lesion
Bi 17 (28)
with side branch
involvement (bi) n
(%), CTO n (%)
Procedural characteristics
Total procedure time
min
Fluoroscopy time
min
Contrast volume, ml
Device time, min

26
(33.3)
18
(23.1)
31
(39.7)
26
(33.3)
3 (3.8)

7 (4)

217 (56.5)

18 (46.1)

21 (54.3)

49(12.8)
112(29.2)

3(7.6)
5(12.8)

8 (8.3)
3 (3.4)

0/111 (0.0)
31/111 (27.9)
53/111 (47.7)
27/111 (24.3)
3.03 ± 0.47

2.87 ± 0.49

3.04 ± 0.53

0.99 ± 0.41

1.21 ± 0.42

1.06 ± 0.36
[381]

0.80 ±
0.3

65.1 ± 14.4

60.0 ± 12.0

65.1 ± 10.8
[381]

78.5 ±
5.8

21.7 ± 11.6

19.5 ± 9.8

21.3 ± 10.3

25.7 ± 12.4

S 27 (87.1)

S 113 (94.2)

86 (71.7)

21

21 ± 16

26.0 ± 11.7
[381]
47.9 ± 18.8

S 64
(82.1),
m 14
(17.9)

384 (100.0)

CTO 2
(2.7)

Bi 115 (29.9)

3.27 ±
0.25

78.5 ± 5.8

33(84.6)

46 (74.4)

34 (28.3)
Bi 36 (30)

92 (70–109)

92.9 ± 36.0

68.3 ± 34.2

27 (18–41)

31.0 ± 15.0

18.0 ± 11.1

294.0 ± 95.9

181.9 ± 66.4
7.9 ± 5.2

53.0 (38.0–74.0)
27.34 ±
18.95
165 ±
63

15.0 (11.0–24.0)

26.5 ± 6

167.9 ± 71.9

167.3 ±
32
(continued on next page)
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Table 2 (continued )
Author

Brinton
(DISRUPT CAD I)
2017 15

Ali ZA (DISRUPT CAD OCT
sub-group) – 2017 16

Ali (DISRUPT CAD II) –
2019 17

No. of lithotripsy
catheters (median
with IQR range or
mean ± SD)
IVL Pressure pre/
post IVL, atm
Number of IVL
Pulses
Pre-dilation n (%)

2 (1, 2)

2(1–2)

1.2 ± 0.6

6/6, atm

4/6, atm

4/6, atm

4/6, atm

6/6, atm

72 (40–120)

94.0 ± 75.0

70.7 ± 43.4

68 ± 25

68.8 ± 31.9

22 (37)

50 (41.7)

212 (55.2)

Post IVL Dilation n
(%)
Catheter Size
(French Fr)
Access TR (n) TF (n)
TU (n) TB (n)

52 (87)

95 (79.2)

32
(41.0)
25
(32.1)
6F (18%
7F)
TF (47),
TR
(29.5)

55.8 ±
14.4
39(100)

78/377 (20.7)

29(74.3)

6F

6F

6F

TR or TF

TR or TF

TR or TF

Max IVL Inflation
pressure atm
OCT Guided
No of Stents
implanted per
lesion (mean)
0
1
2
3
Post stent dilation
balloons used n
(%)
Largest diameter of
post stent dilation
balloon (mean
with SD) mm
Post stent dilation
mean pressure,
atm
Total stent length,
mm
Duration of
hospitalization,
days

6 (19)
1 (1–2)

Hill (DISUPT
CAD III) 2020 20

Lelasi
(SMILE)
2020 19

DISRUPT CAD 4
21

1.2 ± 0.5

5.8 ± 0.7

1 (1, 2)

Aksoy
2019 18

7F
TF (154), TR
(227)
TU (1), TB (2)
6.0 ± 0.3

12
(15.4)
1.3

1.3 ± 0.6

28 (90)

37
(47.4)

6.0 ± 1.2
9 (23.1)

3 (0.8)
289 (75.3)
85 (22.1)
7 (1.8)
377/381 (99.0)

3.8 ±
1.0
30.7 ± 11.9

17 ± 5

31.0 ± 12.0

31.0 ± 12.0

1 (1–1)

2.0 (1.0, 2.0)

26.7 ± 4

Abbreviations: LMA: Left Main Artery; LAD: Left Anterior Descending; RCA: Right Coronary Artery; IVL: Intravascular Lithotripsy; TR: Trans-Radial; TF: TransFemoral; TU: Trans-Ulnar; TB: Trans-Brachial; OCT: Optical Coherence Tomography.

safety and efficacy goals established from the ORBIT II pivotal trial for
orbital atherectomy approval. The primary safety measure was freedom
from MACE to 30 days after the procedure. The primary efficacy
outcome of the study was a procedural success without in-hospital
MACE. An OCT sub-study in 100 patients was also reported [20]. The
study reported that 92.2% of the study population were free from MACE
within 30 days of IVL (p < 0.0001 95% CI), and procedural success was
achieved in up to 92.4% of patients. The mean calcium length, calcium
thickness, and calcium angle was 47.9 ± 18.8 mm, 0.96 ± 0.25 mm, and
292.5 ± 76.5◦ respectively. Our results are consistent with previous
studies reporting an increase in MLD, lumen area at MLA site, and MSA
site. Furthermore, IVL facilitates low-pressure IVL balloon inflation (6
atm), which achieves a remarkable increase in MLD and restenosis
reduction. This is achieved because of calcium fracture and mitigation of
fibro-elastic recoil. Fracture expansion occurs with subsequent stent
implant [8].
Multiple studies have reported different trends of complications of
IVL [15–21]. In terms of complications, MACE reported in most studies
is a combination of cardiac death, TVR, MI, and coronary artery
dissection. The complications of IVL are most commonly due to balloon
inflation or balloon rupture. We found that MI was the most common
complication after IVL at the in-hospital, 30 days, and six-month followup. Coronary artery dissection type B is the second most common

complication after IVL.
The major limitation of all studies was the small sample size and nonrandomized control groups. Our meta-analysis pooled all studies to in
crease the sample size to refine summary estimates to better assess the
safety and effectiveness of IVL. 30-day and 6-month outcomes from
available data show the capacity of IVL to successfully improve the
expansion of the vessel to deploy stents with minimal vessel wall injury
and lower MACE. Our study also highlights the paucity of clinical studies
and the need for further controlled studies on longer follow-up duration.
DISRUPT CAD IV (NCT04151628): was a prospective single-arm
study that enrolled 72 patients from Japan. Subjects were followed at
discharge, 30 days, 6,12, and 24 months. Results from the CAD IV trial
revealed a notable calcium length of 49.8 ± 15.5 mm. Additionally a
calcium angle of 257.9 ± 78.4◦ was concluded by the study, exhibiting
high rates of procedural success and low rates of major adverse cardiac
events [21]. Another ongoing study, RAINBOW (NCT04013906) trial, a
randomized clinical trial to evaluate the plaque modification after
rotational atherectomy vs. IVL before DES implantation.
4.1. Limitations
Due to limited data, only single-arm observational studies were
included; more studies, including randomized, double-blind studies,
7
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Fig. 5. Forest plot showing standard mean differences of lumen area at minimal lumen area (MLA) (A), maximum calcium thickness (MCT) (B), maximum calcium
angle (C) among pre-IVL and post-IVL.

Fig. 6. Forest plot showing standard mean differences of lumen area at minimal stent area (MSA) (A) ,maximum calcium thickness (MCT) (B), maximum calcium
angle (C) among pre-IVL and post-IVL.

should be performed to study the safety and efficacy in a head-to-head
comparison with other calcium debulking procedures. Severe calcifica
tion definition was not uniform in included studies given lack of con
sistency of imaging use including intravascular ultrasounds and optical
coherence tomography. Our result of diameter stenosis had high het
erogeneity, which cannot be excluded given only 2 studies reported
data. Additionally, none of the included studies afforded adjunctive
treatment with atherectomy or specialty cutting balloons. The postprocedural outcomes obtained therefore did account for any form of
adjunctive treatment. Our study predominantly discussed the

angiographic comparison of lesion outcomes pre- and post- IVL. As such,
the studies included did not allow adjunctive treatment with atherec
tomy or specialty cutting balloons. Currently, there is no RCT head-tohead comparison of atherectomy (orbital or rotational) or cutting bal
loons with IVL.
5. Conclusion
Intravascular lithotripsy can offer a significant clinical and angio
graphic success with improvement in the vessel lumen to facilitate
8
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Fig. 7. Stacked bar chart showing complications of intravascular lithotripsy with events shown as bar extension and percentages of events on top of stack bar.

coronary stent delivery and deployments in severely calcified coronary
arteries.
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G.A. Sgueglia, G. Gioffrè, F. Piccioni, A. Gaspardone, Slender distal radial five
French coronary shockwave lithotripsy, Catheterization Cardiovasc. Interventions
94 (3) (2019) 395–398.
B. Wong, S. El-Jack, A. Khan, et al., Treatment of heavily calcified unprotected left
main disease with lithotripsy: the first case series, J. Invasive Cardiol. 31 (6) (2019)
E143–E147.
D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, Research methodes and reporting,
Bmj 8 (2009) 332–336.
S.P. Hozo, B. Djulbegovic, I. Hozo, Estimating the mean and variance from the
median, range, and the size of a sample, BMC Med. Res. Method. 5 (1) (2005) 1–10.
C.H. Lee, S. Cook, J.S. Lee, B. Han, Comparison of two meta-analysis methods:
inverse-variance-weighted average and weighted sum of Z-scores, Genom.
Informat. 14 (4) (2016) 173, https://doi.org/10.5808/GI.2016.14.4.173.
J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in
meta-analyses, BMJ 327 (7414) (2003) 557–560.
M. Egger, G.D. Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a
simple, graphical test, BMJ 315 (7109) (1997) 629–634.
T.J. Brinton, Z.A. Ali, J.M. Hill, I.T. Meredith, A. Maehara, U. Illindala, A. Lansky,
M. Götberg, N.M. Van Mieghem, R. Whitbourn, J. Fajadet, C. Di Mario, Feasibility
of shockwave coronary intravascular lithotripsy for the treatment of calcified
coronary stenoses: first description, Circulation 139 (6) (2019) 834–836.
Z.A. Ali, T.J. Brinton, J.M. Hill, et al., Optical coherence tomography
characterization of coronary lithoplasty for treatment of calcified lesions: first
description, JACC: Cardiovasc. Imaging 10 (8) (2017) 897–906.
Z.A. Ali, H. Nef, J. Escaned, et al., Safety and effectiveness of coronary
intravascular lithotripsy for treatment of severely calcified coronary stenoses: the
disrupt CAD II study, Circulation: Cardiovasc. Interventions 12 (10) (2019)
e008434.
A. Aksoy, C. Salazar, M.U. Becher, et al., Intravascular lithotripsy in calcified
coronary lesions: a prospective, observational, multicenter registry, Circulation:
Cardiovasc. Interventions 12 (11) (2019) e008154.
A. Ielasi, E. Moscarella, L. Testa, G. Gioffrè, G. Morabito, B. Cortese, S. Colangelo,
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